Stephanie Lee, MD, MPH

/content/dam/www/faculty-photos/L/stephanie-lee/stephanie-lee.jpg
Dr. Stephanie Lee MD, MPH
faculty member

Stephanie Lee, MD, MPH

Professor and Associate Director, Clinical Research Division, Fred Hutch

Professor and Associate Director
Clinical Research Division, Fred Hutch

David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research, Fred Hutch

David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research
Fred Hutch

Fax: 206.667.1034
Mail Stop: D5-290

Dr. Stephanie Lee is a hematologist and blood and marrow transplant physician-scientist who treats patients with leukemia, lymphoma and other blood and bone marrow diseases. Her research aims to improve the lives of bone marrow and blood stem cell transplant recipients. She leads a nationwide research network that focuses on improving the understanding of chronic graft-vs.-host disease, or GVHD, and the best ways to prevent, diagnose and treat it. In this common, long-term and sometimes life-threatening transplant complication, donor immune cells attack the recipient’s body. Dr. Lee is especially interested in the chronic form of GVHD, which causes symptoms ranging from painful dry eye and mouth to skin thickening, lung problems and susceptibility to infections. She also studies many other transplant-related topics, including survivorship and patient-reported outcomes. She serves as research director of Fred Hutch’s Long-Term Follow-Up Program, which tracks the outcomes of more than 5,000 transplant survivors.

Other Appointments & Affiliations

Affiliate Investigator, Translational Science and Therapeutics Division, Fred Hutch

Affiliate Investigator
Translational Science and Therapeutics Division, Fred Hutch

Professor, University of Washington

Professor
University of Washington

Past President, American Society of Hematology

Past President
American Society of Hematology

Education

MPH, Harvard School of Public Health, 1996

MD, Stanford University of Medicine, 1990

BS, University of Washington, 1984

Research Interests

Survivorship issues, quality-of-life and the impact of chronic graft-versus-host-disease

"Some of the advances [in hematology research], such as genetically engineered T cells, sound like science fiction, except that the technology is successfully treating blood cancers that previously didn’t respond to other therapies."

— Dr. Stephanie Lee

Find an Active Clinical Trial Led by Dr. Lee